HK Stock MarketDetailed Quotes

REMT (00601)

Watchlist
  • 0.072
  • 0.0000.00%
Market Closed Apr 30 11:34 CST
42.67MMarket Cap-0.13P/E (TTM)

REMT (00601) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
Turnover
-19.32%195.82M
-11.74%93.96M
-7.89%242.7M
3.35%106.45M
-31.36%263.49M
-56.89%103M
-7.73%383.9M
30.83%238.94M
-44.14%416.06M
-50.40%182.63M
Operating income
-19.32%195.82M
-11.74%93.96M
-7.89%242.7M
3.35%106.45M
-31.36%263.49M
-56.89%103M
-7.73%383.9M
30.83%238.94M
-44.14%416.06M
-50.40%182.63M
Cost of sales
16.14%-246.61M
18.20%-107.04M
15.68%-294.08M
5.21%-130.86M
-3.41%-348.77M
23.95%-138.04M
2.88%-337.29M
-12.26%-181.53M
43.50%-347.29M
44.76%-161.7M
Operating expenses
16.14%-246.61M
18.20%-107.04M
15.68%-294.08M
5.21%-130.86M
-3.41%-348.77M
23.95%-138.04M
2.88%-337.29M
-12.26%-181.53M
43.50%-347.29M
44.76%-161.7M
Gross profit
1.13%-50.79M
46.39%-13.08M
39.76%-51.38M
30.36%-24.4M
-282.95%-85.28M
-161.03%-35.04M
-32.22%46.61M
174.27%57.41M
-47.17%68.78M
-72.26%20.93M
Selling expenses
51.66%-1.1M
56.47%-548K
1.56%-2.27M
-34.94%-1.26M
25.12%-2.3M
45.94%-933K
29.86%-3.07M
12.92%-1.73M
48.50%-4.38M
59.22%-1.98M
Administrative expenses
-88.00%-108.14M
-2.74%-31.12M
31.24%-57.52M
38.61%-30.3M
33.72%-83.66M
14.74%-49.35M
-26.72%-126.22M
-22.68%-57.88M
-0.66%-99.61M
-44.76%-47.18M
Impairment and provision
53.89%-115.42M
----
-25.22%-250.33M
-77.19%1.67M
-20.63%-199.91M
112.10%7.31M
30.02%-165.72M
-2,597.95%-60.43M
-14,174.86%-236.82M
---2.24M
-Impairment of intangible assets
-18.11%-12.82M
----
-19.44%-10.85M
----
-864.44%-9.09M
----
65.60%-942K
----
---2.74M
----
-Impairment of property, machinery and equipment
55.33%-104.46M
----
-23.76%-233.84M
----
-222.25%-188.94M
----
66.62%-58.63M
----
---175.66M
----
-Other impairment is provision
132.95%1.86M
----
-199.26%-5.64M
-77.19%1.67M
98.23%-1.88M
112.10%7.31M
-81.68%-106.15M
-2,597.95%-60.43M
-3,421.70%-58.43M
---2.24M
Special items of operating profit
25.19%8.98M
10.06%5.76M
220.14%7.17M
145.50%5.24M
-102.17%-5.97M
-972.40%-11.51M
1,768.93%274.96M
-87.40%1.32M
80.40%14.71M
110.86%10.47M
Operating profit
24.79%-266.47M
20.51%-38.99M
6.04%-354.33M
45.20%-49.05M
-1,520.14%-377.12M
-46.00%-89.52M
110.32%26.56M
-206.47%-61.32M
-980.98%-257.32M
-146.56%-20.01M
Financing cost
-2.90%-56.48M
10.48%-27.53M
-12.48%-54.88M
-29.41%-30.75M
-133.20%-48.79M
4.97%-23.76M
69.85%-20.92M
2.44%-25.01M
29.08%-69.4M
44.00%-25.63M
Earning before tax
21.08%-322.95M
16.64%-66.52M
3.92%-409.21M
29.55%-79.8M
-7,662.34%-425.91M
-31.23%-113.28M
101.72%5.63M
-89.14%-86.32M
-375.94%-326.73M
-1,532.88%-45.64M
Tax
226.96%2.58M
485.31%1.24M
-65.82%790K
379.55%211K
154.66%2.31M
100.45%44K
18.03%-4.23M
-871.16%-9.87M
3.82%-5.16M
89.47%-1.02M
After-tax profit from continuing operations
21.56%-320.37M
17.98%-65.29M
3.58%-408.42M
29.71%-79.59M
-30,270.94%-423.6M
-17.73%-113.24M
100.42%1.4M
-106.17%-96.19M
-348.42%-331.88M
-275.04%-46.66M
Earning after tax
21.56%-320.37M
17.98%-65.29M
3.58%-408.42M
29.71%-79.59M
-30,270.94%-423.6M
-17.73%-113.24M
100.42%1.4M
-106.17%-96.19M
-348.42%-331.88M
-275.04%-46.66M
Profit attributable to shareholders
21.56%-320.37M
17.98%-65.29M
3.58%-408.42M
29.71%-79.59M
-30,270.94%-423.6M
-17.73%-113.24M
100.42%1.4M
-106.17%-96.19M
-348.42%-331.88M
-275.04%-46.66M
Basic earnings per share
21.56%-0.5406
15.38%-0.11
13.23%-0.6892
53.57%-0.13
-26,576.67%-0.7943
-1,817.81%-0.28
129.70%0.003
-105.63%-0.0146
9.82%-0.0101
-273.68%-0.0071
Diluted earnings per share
21.56%-0.5406
15.38%-0.11
13.23%-0.6892
53.57%-0.13
-26,576.67%-0.7943
-1,817.81%-0.28
129.70%0.003
-105.63%-0.0146
9.82%-0.0101
-273.68%-0.0071
Currency Unit
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
--
--
Auditor
--
--
Bai Chun Accounting Firm Limited
--
Shanghui Baicheng Certified Public Accountants LLP
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021
Turnover -19.32%195.82M-11.74%93.96M-7.89%242.7M3.35%106.45M-31.36%263.49M-56.89%103M-7.73%383.9M30.83%238.94M-44.14%416.06M-50.40%182.63M
Operating income -19.32%195.82M-11.74%93.96M-7.89%242.7M3.35%106.45M-31.36%263.49M-56.89%103M-7.73%383.9M30.83%238.94M-44.14%416.06M-50.40%182.63M
Cost of sales 16.14%-246.61M18.20%-107.04M15.68%-294.08M5.21%-130.86M-3.41%-348.77M23.95%-138.04M2.88%-337.29M-12.26%-181.53M43.50%-347.29M44.76%-161.7M
Operating expenses 16.14%-246.61M18.20%-107.04M15.68%-294.08M5.21%-130.86M-3.41%-348.77M23.95%-138.04M2.88%-337.29M-12.26%-181.53M43.50%-347.29M44.76%-161.7M
Gross profit 1.13%-50.79M46.39%-13.08M39.76%-51.38M30.36%-24.4M-282.95%-85.28M-161.03%-35.04M-32.22%46.61M174.27%57.41M-47.17%68.78M-72.26%20.93M
Selling expenses 51.66%-1.1M56.47%-548K1.56%-2.27M-34.94%-1.26M25.12%-2.3M45.94%-933K29.86%-3.07M12.92%-1.73M48.50%-4.38M59.22%-1.98M
Administrative expenses -88.00%-108.14M-2.74%-31.12M31.24%-57.52M38.61%-30.3M33.72%-83.66M14.74%-49.35M-26.72%-126.22M-22.68%-57.88M-0.66%-99.61M-44.76%-47.18M
Impairment and provision 53.89%-115.42M-----25.22%-250.33M-77.19%1.67M-20.63%-199.91M112.10%7.31M30.02%-165.72M-2,597.95%-60.43M-14,174.86%-236.82M---2.24M
-Impairment of intangible assets -18.11%-12.82M-----19.44%-10.85M-----864.44%-9.09M----65.60%-942K-------2.74M----
-Impairment of property, machinery and equipment 55.33%-104.46M-----23.76%-233.84M-----222.25%-188.94M----66.62%-58.63M-------175.66M----
-Other impairment is provision 132.95%1.86M-----199.26%-5.64M-77.19%1.67M98.23%-1.88M112.10%7.31M-81.68%-106.15M-2,597.95%-60.43M-3,421.70%-58.43M---2.24M
Special items of operating profit 25.19%8.98M10.06%5.76M220.14%7.17M145.50%5.24M-102.17%-5.97M-972.40%-11.51M1,768.93%274.96M-87.40%1.32M80.40%14.71M110.86%10.47M
Operating profit 24.79%-266.47M20.51%-38.99M6.04%-354.33M45.20%-49.05M-1,520.14%-377.12M-46.00%-89.52M110.32%26.56M-206.47%-61.32M-980.98%-257.32M-146.56%-20.01M
Financing cost -2.90%-56.48M10.48%-27.53M-12.48%-54.88M-29.41%-30.75M-133.20%-48.79M4.97%-23.76M69.85%-20.92M2.44%-25.01M29.08%-69.4M44.00%-25.63M
Earning before tax 21.08%-322.95M16.64%-66.52M3.92%-409.21M29.55%-79.8M-7,662.34%-425.91M-31.23%-113.28M101.72%5.63M-89.14%-86.32M-375.94%-326.73M-1,532.88%-45.64M
Tax 226.96%2.58M485.31%1.24M-65.82%790K379.55%211K154.66%2.31M100.45%44K18.03%-4.23M-871.16%-9.87M3.82%-5.16M89.47%-1.02M
After-tax profit from continuing operations 21.56%-320.37M17.98%-65.29M3.58%-408.42M29.71%-79.59M-30,270.94%-423.6M-17.73%-113.24M100.42%1.4M-106.17%-96.19M-348.42%-331.88M-275.04%-46.66M
Earning after tax 21.56%-320.37M17.98%-65.29M3.58%-408.42M29.71%-79.59M-30,270.94%-423.6M-17.73%-113.24M100.42%1.4M-106.17%-96.19M-348.42%-331.88M-275.04%-46.66M
Profit attributable to shareholders 21.56%-320.37M17.98%-65.29M3.58%-408.42M29.71%-79.59M-30,270.94%-423.6M-17.73%-113.24M100.42%1.4M-106.17%-96.19M-348.42%-331.88M-275.04%-46.66M
Basic earnings per share 21.56%-0.540615.38%-0.1113.23%-0.689253.57%-0.13-26,576.67%-0.7943-1,817.81%-0.28129.70%0.003-105.63%-0.01469.82%-0.0101-273.68%-0.0071
Diluted earnings per share 21.56%-0.540615.38%-0.1113.23%-0.689253.57%-0.13-26,576.67%-0.7943-1,817.81%-0.28129.70%0.003-105.63%-0.01469.82%-0.0101-273.68%-0.0071
Currency Unit HKDHKDHKDHKDHKDHKDHKDHKDHKDHKD
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions ----Unqualified Opinion--Unqualified Opinion--Unqualified Opinion------
Auditor ----Bai Chun Accounting Firm Limited--Shanghui Baicheng Certified Public Accountants LLP--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More